DUBLIN, March 22, 2018 /PRNewswire/ --
The "Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering.
The Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter Regenerative Medicine partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.
This report provides details of the latest Regenerative Medicine agreements announced in the life sciences since 2012.
The report takes the reader through a comprehensive review Regenerative Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Regenerative Medicine partnering deals.
The report presents financial deal term values for Regenerative Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
One of the key highlights of the report is that over 950 online deal records of actual Regenerative Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.
Key benefits
- In-depth understanding of Regenerative Medicine deal trends since 2012
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Regenerative Medicine agreements with numerous real life case studies
- Detailed access to actual Regenerative Medicine contracts entered into by leading biopharma companies
- Identify most active Regenerative Medicine dealmakers since 2012
- Insight into terms included in a Regenerative Medicine partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Report scope
Regenerative Medicine Partnering Terms and Agreements includes:
- Trends in Regenerative Medicine dealmaking in the biopharma industry since 2012
- Analysis of Regenerative Medicine deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Regenerative Medicine deals
- Access to Regenerative Medicine contract documents
- Leading Regenerative Medicine deals by value since 2012
- Most active Regenerative Medicine dealmakers since 2012
In Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
For more information about this report visit https://www.researchandmarkets.com/research/27hkpc/global?w=5
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-regenerative-medicine-partnering-directory-2018-trends-players-financials-and-forecasts-for-950-deals-300618215.html
SOURCE Research and Markets